Advancing innovative lung cancer research proposals
Developmental Research Program
This program is all about helping researchers come up with new ideas to fight lung cancer, and it’s open to both new and experienced scientists, especially those from diverse backgrounds, so that we can find better treatments and care for patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Dana-Farber Cancer Inst NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10891404 on NIH RePORTER |
What this research studies
This program aims to support the development of innovative research projects focused on lung cancer by providing funding for promising proposals from both junior and senior investigators. It encourages collaboration and the submission of diverse research ideas, particularly from underrepresented groups. The program will facilitate a formal review process to ensure that the most impactful projects receive funding, ultimately leading to advancements in lung cancer treatment and understanding. Patients may benefit from the outcomes of these projects as they could lead to new therapies and improved care.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals affected by lung cancer or those at high risk for developing the disease.
Not a fit: Patients with cancers unrelated to lung cancer may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to groundbreaking advancements in lung cancer treatment and management.
How similar studies have performed: Previous research initiatives focused on lung cancer have shown promise in advancing treatment options, indicating that this approach has the potential for success.
Where this research is happening
Boston, United States
- Dana-Farber Cancer Inst — Boston, United States (Active)
Researchers
- Principal investigator: Heist, Rebecca Suk — Dana-Farber Cancer Inst
- Study coordinator: Heist, Rebecca Suk
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.